Study in Healthy Volunteers to Investigate the Effects of Rifampin on the Pharmacokinetics of NKTR-118

NCT01533870 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Induced Constipation

Interventions

DRUG: NKTR-118
DRUG: Rifampin

Sponsor

AstraZeneca